Armstrong, Fleming & Moore, Inc
- SEC CIK
- 0001990099
- Latest filing
- Jul 28, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Armstrong, Fleming & Moore, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,173
- Value
- $248.0K
- % of portfolio
- 0.1%
- Quarters held
- 11
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,173 | $248.0K | 0.1% | +5,173 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −5,878−100.0% | Sold out | Holders |
| Q4 2025 | 5,878 | $299.1K | 0.1% | −234−3.8% | Reduced | Holders |
| Q3 2025 | 6,112 | $339.2K | 0.2% | +806+15.2% | Added | Holders |
| Q2 2025 | 5,306 | $366.2K | 0.2% | +5,306 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −5,924−100.0% | Sold out | Holders |
| Q4 2024 | 5,924 | $509.6K | 0.3% | −1,608−21.3% | Reduced | Holders |
| Q3 2024 | 7,532 | $896.9K | 0.5% | +500+7.1% | Added | Holders |
| Q2 2024 | 7,032 | $1.00M | 0.6% | +2,374+51.0% | Added | Holders |
| Q1 2024 | 4,658 | $598.1K | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2023 | 4,658 | $481.9K | 0.4% | 00.0% | Unchanged | Holders |
| Q3 2023 | 4,658 | $423.6K | 0.4% | +330+7.6% | AddedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 2,164 | $350.2K | 0.3% | – | No prior filing | Holders |